A ruling in late June by the US Supreme Court is expected to result in more crime lab analysts having to testify at trial. In a 5-to-4 decision, the Court ruled that the confrontation clause of the US Constitution’s Sixth Amendment entitles criminal defendants to confront witnesses against them. As a result, lab analysts may […]

The American Chemistry Council (ACC) estimates that the chemical industry’s downturn is moderating. The ACC forecasts worldwide chemical output to fall 6.3% this year, before increasing 2.8% in 2010 and 4.0% in 2011. By geographic region, Africa and the Middle East are expected to be the strongest in 2009, with output declining only 1.4%. In […]

Biologics will account for seven of the top 10 selling drugs in five years and half of the top 100 selling drugs, according to EvaluatePharma. Last year, five of the 10 top selling drugs were biologics and 28% of the top 100 were biologics. Of the biologics in the top 5 in 2014, five are […]

Generic drug firms are facing a tougher business environment. In efforts to cut spending, some European countries, have recently reduced the prices they pay for generics. As a result, generic makers are less likely to bid for the contracts, which has allowed the makers of branded drugs to secure the contracts and make a profit […]

Updating its 2008 R&D survey (see IBO 12/31/08), Battelle and R&D Magazine now estimate that total R&D spending for 40 countries will grow 1.6% to $1.125 trillion this year, compared to the earlier estimate of a 3.2% increase. The update accounts for stimulus plans and the continuing recession. A survey of readers of four magazines […]